Coronavirus Research Hub
Welcome to the Elsevier Coronavirus Research Hub
We invite researchers and data scientists focused on Coronavirus vaccine, drug, clinical and other related research, to freely access these Elsevier solutions for your work.
Get accessElsevier coronavirus and Covid-19 related full text articles and chapters will be provided for as long as needed while the public health emergency is ongoing. Research tools and selected Virology and Infectious Disease Journals are open to coronavirus researchers through April 30th, 2021.
Made for researchers in the following segments
Get access to these best-in-class tools
Find and apply the current clinical understanding of coronavirus related pathophysiology, diagnosis and treatment.
Learn more | Get support | Register
Sign in (registered users)
Surface drug-disease relationships, drug-drug interactions, treatments used in similar pathologies, and suitable animal models for testing.
Learn more | Get support | Register
Sign in (registered users)
Quickly find up-to-the minute research on Covid-19 via this open-access online preprint community.
Learn more | Register
Sign in (registered users)
Identify potential research collaborators in areas related to the coronavirus epidemic across basic science, translational research, or clinical practice.
Learn more | Coronavirus Portal
Organize your COVID-19 research, collaborate with others online, and discover the latest research
Learn more | Get support | Register
Sign in (registered users)
Discover, collect, share and publish COVID-19 research data
Find data | Explore metadata
Publish data
Find precise biomedical information from > 14 million full-text articles from multiple publishers, in addition to smarter searching and interrogation of the CORD-19 dataset.
Learn more | Register
Sign in (registered users)
Gain full text access to Cell, The Lancet, Trends in Microbiology, Antiviral Research, and 70+ other relevant journals.
Register | Sign in (registered users)
Continue to build your knowledge from >30,000 novel coronavirus related full text articles and chapters.
Go to research corpus
Obtain full drug candidate profiles, analyzed and ranked based on your submitted criteria.
Learn more | Register
In Mendeley Data investigate biological relationships between diseases (MERS and SARS), proteins and molecules, all extracted from Pathway Studio.
Go to data
Search for the molecules that modulate the target proteins, find synthetic routes, scale up the synthetic routes with GMP compliance.
Learn more | Register
Sign in (registered users)
Analyze coronavirus and COVID-19 specific research output, find and assess collaborators.
Learn more | Get support | Register
Sign in (registered users)
Understand Safety Toxicology and DMPK properties of drug candidates using FDA and EMA data on approved drugs. Predict drug-drug interaction risks.
Learn more | Get support | Register
Sign in (registered users)
Find COVID-related research funding opportunities and receive alerts regarding new funding sources.
Learn more | Get support | Register
Sign in (registered users)
Collect, and safely store, patient level data in a consistent and secure manner during clinical development and other patient-related studies.
Learn more | Register
In collaboration with
Collection of data sets made freely available to public health and policy researchers to extract insights for combatting the
COVID-19 pandemic.
Neo4j hosts the knowledge graph of COVID-19 protein regulation extracted from biomedical papers with Elsevier Text Mining
Showcases
Clinical research platform for managing COVID-19 patient data and beyond
by Anna Lewandowska (Clinical Trials Implementation Manager)
Drug Repurposing for SARS-CoV-2 Using Network Polypharmacological Approach
by Helena Deus (Senior Technology Researcher)
Ready to take the next step?
The Elsevier Coronavirus Research Hub is waiting for you.
More for Health Researchers:
Elsevier COVID-19 Healthcare Hub